Skip to main content

Alexandria Real Estate Equities company profile

  • ARE · NYSE
  • Real estate
  • Office REITs
  • S&P 500
$43.84−1.04%Close 13 Nov 2026 · Market value $7.54B

About Alexandria Real Estate Equities

Alexandria Real Estate Equities, Inc. is a life science REIT that owns, operates, and develops collaborative Megacampus ecosystems in AAA life science innovation clusters, including Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City. As of December 31, 2025, its North American portfolio comprised 340 properties with approximately 39.4 million RSF of operating and Class A/A+ development and redevelopment properties under construction, and its operating properties were 90.9% occupied. Tenants include multinational pharmaceutical companies, biotechnology companies, medical device and digital health companies, academic and medical research institutions, U.S. government research agencies, and venture capital firms. The company also makes investments in publicly traded and privately held life science entities.

A summary of the business section of the company's latest annual report, filed 26 Jan 2026.

Company facts

TickerARE · NYSE
SectorReal estate
IndustryOffice REITs
IndexS&P 500
Fiscal year ends31 December
Reporting currencyUSD
CIK1035443
Latest annual report10-K, filed 26 Jan 2026

Officers and directors

NameRoleShares ownedLatest Form 4
Joel S. MarcusExecutive Chairman · Director563K · < 1%Open-market purchase, 11 Sep 2026
Peter M. MogliaChief Executive Officer378K · < 1%Shares withheld for tax, 30 Sep 2026
Hunter L. KassCo-President and RMD237K · < 1%Shares withheld for tax, 23 Jan 2026
Marc E. BindaCFO & Treasurer190K · < 1%Sale under a 10b5-1 plan, 9 Jun 2026
Lawrence J. DiamondCo-Chief Operating Officer160K · < 1%Disposition to the issuer, 23 Jan 2026
John Hart ColeCo-President, & Co-RMD109K · < 1%Shares withheld for tax, 15 Sep 2026
Michael A. WoronoffDirector21.4K · < 1%Grant or award, 30 Sep 2026
Richard H. KleinDirector15.7K · < 1%Grant or award, 15 Jul 2026
Maria C. Freire, PhDDirector10.9K · < 1%Grant or award, 15 Jan 2026
James P. CainDirector7.2K · < 1%Grant or award, 15 Jul 2026
Sheila K. McGrathDirector6.3K · < 1%Grant or award, 15 Oct 2026
Claire Aldridge, PhDDirector4.5K · < 1%Grant or award, 15 Jan 2026
Hash SteveDirector—Grant or award, 15 Oct 2026
Thomas Gregory CalvinEVP - CTO—Shares withheld for tax, 15 Sep 2026
Nelson Jesse J.EVP - RMD—Shares withheld for tax, 15 Sep 2026
Gossett Bret E.EVP - Co-RMD—Shares withheld for tax, 15 Sep 2026
Kuhn Hallie E.EVP - Cap Market & Co-Lead -LS—Shares withheld for tax, 15 Sep 2026
Foger Jenna R.EVP - Co-Lead - Life Science—Shares withheld for tax, 15 Sep 2026
Stevens Blake L.Regional Market Director—Shares withheld for tax, 15 Sep 2026
Boss Michael E.Co-Regional Market Director—Shares withheld for tax, 15 Sep 2026

Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.

ARE in the terminal

The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.